| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | INFU Infusystem Holdings, Inc | Dilorio Richard68 | Chief Executive Officer | Sell | 40,000 | $9.11 | $364,465.73 | -3.0% | -11.7% | +4.7% | |
| Nov 27, 2024 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 2,000 | $249.67 | $499,330.00 | -100% | -5.3% | +2.6% | |
| Nov 26, 2024 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 581 | $27.20 | $15,803.20 | -0.5% | -5.0% | -1.4% | |
| Nov 26, 2024 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 216 | $27.20 | $5,875.20 | -0.4% | -5.0% | -1.4% | |
| Nov 26, 2024 | RXST Rxsight, Inc. | Maniar Shweta62 | Director | Sell | 3,782 | $45.88 | $173,518.16 | -25.8% | -36.4% | -75.0% | |
| Nov 26, 2024 | ISRG Intuitive Surgical Inc | Samath Jamie62 | CFO And Head Of Business Techn | Sell | 108 | $542.06 | $58,542.48 | -0.6% | +9.1% | +5.9% | |
| Nov 26, 2024 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Strategy &Corp Op | Sell | 396 | $542.06 | $214,655.76 | -3.5% | +9.1% | +5.9% | |
| Nov 26, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 523 | $27.20 | $14,225.60 | -0.2% | -5.0% | -1.4% | |
| Nov 26, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 20,111 | $0.62 | $12,372.29 | +0.1% | +33.6% | +33.9% | |
| Nov 26, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 349 | $27.20 | $9,492.80 | -0.3% | -5.0% | -1.4% | |
| Nov 26, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 252 | $27.20 | $6,854.40 | -0.2% | -5.0% | -1.4% | |
| Nov 26, 2024 | VMD Viemed Healthcare, Inc. | Kaushal Nitin82 | Director | Sell | 30,000 | $8.68 | $260,280.60 | -10.6% | -11.0% | -20.6% | |
| Nov 26, 2024 | ICUI Icu Medical Inc/de | Voigtlander Christian B.64 | Chief Operating Officer | Sell | 9,681 | $161.13 | $1,559,917.00 | -97.9% | +1.7% | -5.5% | |
| Nov 26, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 6,200 | $45.44 | $281,728.00 | -6.8% | -36.4% | -75.0% | |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Spoor Johan M. | CEO | Buy | 26,500 | $3.79 | $100,468.00 | +13.4% | -26.0% | -40.7% | |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 12,829 | $3.82 | $48,974.26 | +8.7% | -26.0% | -40.7% | |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Williamson Robert F III63 | Director | Buy | 6,266 | $3.64 | $22,813.51 | +0.7% | -26.0% | -40.7% | |
| Nov 25, 2024 | SSII Ss Innovations International, Inc. | Srivastava Sudhir | Chairman And CEO | Sell | 7,289,539 | $1.37 | $10,001,247.51 | -6.3% | - | - | |
| Nov 25, 2024 | LFWD Lifeward Ltd. | Swinford Michael | Director | Buy | 21,622 | $2.03 | $43,858.06 | +49.8% | -22.2% | -71.9% | |
| Nov 25, 2024 | SSII Ss Innovations International, Inc. | Moll Frederic H | Director | Buy | 3,644,315 | $1.37 | $5,000,000.18 | +623.3% | - | - | |
| Nov 25, 2024 | BSX Boston Scientific Corp | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sell | 14,010 | $89.27 | $1,250,664.29 | -93.5% | +17.0% | +13.6% | |
| Nov 25, 2024 | STE Steris Plc | Majors Cary L54 | SVP And President, Healthcare | Sell | 1,682 | $217.32 | $365,532.24 | -12.9% | +3.5% | +23.9% | |
| Nov 22, 2024 | RMD Resmed Inc | Leong Justin | Chief Product Officer | Sell | 6,160 | $243.09 | $1,497,415.92 | -22.1% | -4.5% | +2.9% | |
| Nov 22, 2024 | TLSI Trisalus Life Sciences, Inc. | Wahlstrom Mats58 | Director, 10% Owner | Buy | 5,000 | $4.55 | $22,750.00 | +46.6% | +26.3% | +11.9% | |
| Nov 22, 2024 | LUNG Pulmonx Corp | French Glendon E. III84 | Director | Sell | 20,000 | $6.63 | $132,600.00 | -1.8% | +29.3% | -78.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.